Cargando…

The Cool Little Kids randomised controlled trial: Population-level early prevention for anxiety disorders

BACKGROUND: The World Health Organization predicts that by 2030 internalising problems (e.g. depression and anxiety) will be second only to HIV/AIDS in international burden of disease. Internalising problems affect 1 in 7 school aged children, impacting on peer relations, school engagement, and late...

Descripción completa

Detalles Bibliográficos
Autores principales: Bayer, Jordana K, Rapee, Ronald M, Hiscock, Harriet, Ukoumunne, Obioha C, Mihalopoulos, Cathrine, Clifford, Susan, Wake, Melissa
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3027133/
https://www.ncbi.nlm.nih.gov/pubmed/21208451
http://dx.doi.org/10.1186/1471-2458-11-11
_version_ 1782197125813108736
author Bayer, Jordana K
Rapee, Ronald M
Hiscock, Harriet
Ukoumunne, Obioha C
Mihalopoulos, Cathrine
Clifford, Susan
Wake, Melissa
author_facet Bayer, Jordana K
Rapee, Ronald M
Hiscock, Harriet
Ukoumunne, Obioha C
Mihalopoulos, Cathrine
Clifford, Susan
Wake, Melissa
author_sort Bayer, Jordana K
collection PubMed
description BACKGROUND: The World Health Organization predicts that by 2030 internalising problems (e.g. depression and anxiety) will be second only to HIV/AIDS in international burden of disease. Internalising problems affect 1 in 7 school aged children, impacting on peer relations, school engagement, and later mental health, relationships and employment. The development of early childhood prevention for internalising problems is in its infancy. The current study follows two successful 'efficacy' trials of a parenting group intervention to reduce internalising disorders in temperamentally inhibited preschool children. Cool Little Kids is a population-level randomised trial to determine the impacts of systematically screening preschoolers for inhibition then offering a parenting group intervention, on child internalising problems and economic costs at school entry. METHODS/DESIGN: This randomised trial will be conducted within the preschool service system, attended by more than 95% of Australian children in the year before starting school. In early 2011, preschool services in four local government areas in Melbourne, Australia, will distribute the screening tool. The ≈16% (n≈500) with temperamental inhibition will enter the trial. Intervention parents will be offered Cool Little Kids, a 6-session group program in the local community, focusing on ways to develop their child's bravery skills by reducing overprotective parenting interactions. Outcomes one and two years post-baseline will comprise child internalising diagnoses and symptoms, parenting interactions, and parent wellbeing. An economic evaluation (cost-consequences framework) will compare incremental differences in costs of the intervention versus control children to incremental differences in outcomes, from a societal perspective. Analyses will use the intention-to-treat principle, using logistic and linear regression models (binary and continuous outcomes respectively) to compare outcomes between the trial arms. DISCUSSION: This trial addresses gaps for internalising problems identified in the 2004 World Health Organization Prevention of Mental Disorders report. If effective and cost-effective, the intervention could readily be applied at a population level. Governments consider mental health to be a priority, enhancing the likelihood that an effective early prevention program would be adopted in Australia and internationally. TRIAL REGISTRATION: ISRCTN: ISRCTN30996662 RCH HUMAN RESEARCH ETHICS APPROVAL: 30105A
format Text
id pubmed-3027133
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30271332011-01-27 The Cool Little Kids randomised controlled trial: Population-level early prevention for anxiety disorders Bayer, Jordana K Rapee, Ronald M Hiscock, Harriet Ukoumunne, Obioha C Mihalopoulos, Cathrine Clifford, Susan Wake, Melissa BMC Public Health Study Protocol BACKGROUND: The World Health Organization predicts that by 2030 internalising problems (e.g. depression and anxiety) will be second only to HIV/AIDS in international burden of disease. Internalising problems affect 1 in 7 school aged children, impacting on peer relations, school engagement, and later mental health, relationships and employment. The development of early childhood prevention for internalising problems is in its infancy. The current study follows two successful 'efficacy' trials of a parenting group intervention to reduce internalising disorders in temperamentally inhibited preschool children. Cool Little Kids is a population-level randomised trial to determine the impacts of systematically screening preschoolers for inhibition then offering a parenting group intervention, on child internalising problems and economic costs at school entry. METHODS/DESIGN: This randomised trial will be conducted within the preschool service system, attended by more than 95% of Australian children in the year before starting school. In early 2011, preschool services in four local government areas in Melbourne, Australia, will distribute the screening tool. The ≈16% (n≈500) with temperamental inhibition will enter the trial. Intervention parents will be offered Cool Little Kids, a 6-session group program in the local community, focusing on ways to develop their child's bravery skills by reducing overprotective parenting interactions. Outcomes one and two years post-baseline will comprise child internalising diagnoses and symptoms, parenting interactions, and parent wellbeing. An economic evaluation (cost-consequences framework) will compare incremental differences in costs of the intervention versus control children to incremental differences in outcomes, from a societal perspective. Analyses will use the intention-to-treat principle, using logistic and linear regression models (binary and continuous outcomes respectively) to compare outcomes between the trial arms. DISCUSSION: This trial addresses gaps for internalising problems identified in the 2004 World Health Organization Prevention of Mental Disorders report. If effective and cost-effective, the intervention could readily be applied at a population level. Governments consider mental health to be a priority, enhancing the likelihood that an effective early prevention program would be adopted in Australia and internationally. TRIAL REGISTRATION: ISRCTN: ISRCTN30996662 RCH HUMAN RESEARCH ETHICS APPROVAL: 30105A BioMed Central 2011-01-05 /pmc/articles/PMC3027133/ /pubmed/21208451 http://dx.doi.org/10.1186/1471-2458-11-11 Text en Copyright ©2011 Bayer et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Study Protocol
Bayer, Jordana K
Rapee, Ronald M
Hiscock, Harriet
Ukoumunne, Obioha C
Mihalopoulos, Cathrine
Clifford, Susan
Wake, Melissa
The Cool Little Kids randomised controlled trial: Population-level early prevention for anxiety disorders
title The Cool Little Kids randomised controlled trial: Population-level early prevention for anxiety disorders
title_full The Cool Little Kids randomised controlled trial: Population-level early prevention for anxiety disorders
title_fullStr The Cool Little Kids randomised controlled trial: Population-level early prevention for anxiety disorders
title_full_unstemmed The Cool Little Kids randomised controlled trial: Population-level early prevention for anxiety disorders
title_short The Cool Little Kids randomised controlled trial: Population-level early prevention for anxiety disorders
title_sort cool little kids randomised controlled trial: population-level early prevention for anxiety disorders
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3027133/
https://www.ncbi.nlm.nih.gov/pubmed/21208451
http://dx.doi.org/10.1186/1471-2458-11-11
work_keys_str_mv AT bayerjordanak thecoollittlekidsrandomisedcontrolledtrialpopulationlevelearlypreventionforanxietydisorders
AT rapeeronaldm thecoollittlekidsrandomisedcontrolledtrialpopulationlevelearlypreventionforanxietydisorders
AT hiscockharriet thecoollittlekidsrandomisedcontrolledtrialpopulationlevelearlypreventionforanxietydisorders
AT ukoumunneobiohac thecoollittlekidsrandomisedcontrolledtrialpopulationlevelearlypreventionforanxietydisorders
AT mihalopouloscathrine thecoollittlekidsrandomisedcontrolledtrialpopulationlevelearlypreventionforanxietydisorders
AT cliffordsusan thecoollittlekidsrandomisedcontrolledtrialpopulationlevelearlypreventionforanxietydisorders
AT wakemelissa thecoollittlekidsrandomisedcontrolledtrialpopulationlevelearlypreventionforanxietydisorders
AT bayerjordanak coollittlekidsrandomisedcontrolledtrialpopulationlevelearlypreventionforanxietydisorders
AT rapeeronaldm coollittlekidsrandomisedcontrolledtrialpopulationlevelearlypreventionforanxietydisorders
AT hiscockharriet coollittlekidsrandomisedcontrolledtrialpopulationlevelearlypreventionforanxietydisorders
AT ukoumunneobiohac coollittlekidsrandomisedcontrolledtrialpopulationlevelearlypreventionforanxietydisorders
AT mihalopouloscathrine coollittlekidsrandomisedcontrolledtrialpopulationlevelearlypreventionforanxietydisorders
AT cliffordsusan coollittlekidsrandomisedcontrolledtrialpopulationlevelearlypreventionforanxietydisorders
AT wakemelissa coollittlekidsrandomisedcontrolledtrialpopulationlevelearlypreventionforanxietydisorders